Cargando…

Letter to the Editor: Entecavir Treatment Restores the Anti‐HBV Immune response?

Detalles Bibliográficos
Autores principales:	Beudeker, Boris J.B., Janssen, Harry L.A., Boonstra, Andre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519098/ https://www.ncbi.nlm.nih.gov/pubmed/34107087 http://dx.doi.org/10.1002/hep.32003

Ejemplares similares

Response to Letter to the Editor
por: Mondal, Monidipa, et al.
Publicado: (2021)

Response to the letter to the editor
por: Olry de Labry Lima, Antonio, et al.
Publicado: (2021)

Response to letter to the editor
por: Sridharan, Aadhavi, et al.
Publicado: (2022)

Response to Letter to the Editor
por: Beijer, Elise, et al.
Publicado: (2022)

Response to Letter to the Editor
por: Adeniji, Folashayo, et al.
Publicado: (2023)

Letter to Editor-response: placebo response rates
por: Gyawali, Bishal
Publicado: (2023)

Letter to the Editor
por: Dharmadhikari, Ashwin S., et al.
Publicado: (2011)

Letter to Editor
por: Şahan, Ekrem, et al.
Publicado: (2017)

Letter to the Editor
por: Goldsborough, Sarah
Publicado: (2018)

Letter to Editor
por: Saks, Michael J.
Publicado: (2021)

Letter to Editor
por: Ditrich, Hans
Publicado: (2021)

Letter to the Editor
por: Narayan, Ishir
Publicado: (2023)

Letter to the Editor in Response to Zhou et al
por: Troth, Sean, et al.
Publicado: (2021)

Photobiomodulation therapy and the clinical reality in Brazil: response to the letter to the editor
por: de Paula Gomes, Cid André Fidelis, et al.
Publicado: (2021)

Reply to letter to the editor
por: Kvasnovsky, Charlotte L., et al.
Publicado: (2020)

Letter to the editor: Reply
por: Shim, Jung-Woo, et al.
Publicado: (2021)

Letter to the editor response
por: Krawiec, Conrad, et al.
Publicado: (2022)

Letter to the editor in response to Komen et al. 2021
por: Kumar, Niraj S, et al.
Publicado: (2021)

Letter to the editor in response to Kobo et al. 2022
por: Kageyama, Shigetaka, et al.
Publicado: (2022)

Letter to the Editor: Getting to the True Values of Thyroglobulin and Anti-Thyroglobulin Antibodies
por: Kurien, Biji T., et al.
Publicado: (2016)

Response to letter to the editor concerning validation of IOTA ADNEX model
por: Szubert, Sebastian, et al.
Publicado: (2016)

Circulating biomarkers for early detection of hepatocellular carcinoma
por: Beudeker, Boris J. B., et al.
Publicado: (2020)

Letter to the Editor: Comment on Predatory Journals
por: Jawad, Fatema
Publicado: (2017)

Making life simple—Letter to the Editor
por: Artemiou, Panagiotis
Publicado: (2017)

Authors’ reply to Hansel’s letter to the editor
por: Kotani, Yuki, et al.
Publicado: (2023)

Letter to the Editor: Supporting the Sick and the Vulnerable
por: del Castillo, Fides A.
Publicado: (2023)

Response to letter to the editor: Why does Leigh syndrome responds to immunotherapy?
por: Chuquilin, Miguel, et al.
Publicado: (2016)

Letter to the Editor: Serum anti-Müllerian hormone levels and phenotypes of polycystic ovary syndrome
por: Joob, Beuy, et al.
Publicado: (2013)

Letter to the Editor: Chronic Kidney Disease - a Neglected Disease in the Economic Conditions Burden Analysis in Korea
por: Bikbov, Boris
Publicado: (2019)

Letter to the Editor: Publication Activity of Scientific Authors
por: Joob, Beuy, et al.
Publicado: (2016)

Letter to the Editor: COVID-19 ‘Solutions’ in Bangladesh
por: Al-Zaman, Md. Sayeed
Publicado: (2021)

Response to letters to the editor regarding ‘feasibility of radiation therapist–performed treatment reviews’
por: Monk, Clare M, et al.
Publicado: (2013)

Response to the letter to the editor: Complete heart block and Takotsubo syndrome: Dissecting the pathophysiology
por: Rathore, Abhishek, et al.
Publicado: (2018)

Response to Letter to the Editor 'The lost art of proper patient examination in the technology era’
por: Beard, Jonathan
Publicado: (2020)

Response to Letter to the Editor: Secondary ganglioside G(M2) accumulation in mucopolysaccharidoses
por: Derrick-Roberts, Ainslie L.K.
Publicado: (2021)

Response to Letter to the editor on: “Never too late? Quadruplets at the age of 65 years”
por: Hinkson, Larry, et al.
Publicado: (2021)

Letter to the Editor: Strengthening the Disaster Response of the Philippines for a Better Healthcare System
por: Cordero, Dalmacito A.
Publicado: (2023)

HIV-1 with HBV-associated Q151M substitution in RT becomes highly susceptible to entecavir: structural insights into HBV-RT inhibition by entecavir
por: Yasutake, Yoshiaki, et al.
Publicado: (2018)

Response to: Kumar N, Ahmed M. Letter to the editor in response to Komen et al. 2021
por: Komen, Joris J, et al.
Publicado: (2021)

Renal safety of tenofovir and/or entecavir in patients with chronic HBV monoinfection
por: Yang, Young-Mo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_09m86j05vflsfr4h7tel20jvi2